Harvard Apparatus Regenerative Technology, Inc. (HRGN) › Operating Cash FlowHarvard Apparatus Regenerative Technology, Inc. (HRGN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$9.06M2017: -$11.01M2018: -$7.64M2019: -$6.06M2020: -$4.04M2021: -$2.63M2022: -$5.11M2023: -$6.94M2024: -$4.85M2025: -$3.83M-$3.83M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$3.83M+21.1%2024-$4.85M+30.1%2023-$6.94M-35.9%2022-$5.11M-94.3%2021-$2.63M+35.0%2020-$4.04M+33.3%2019-$6.06M+20.7%2018-$7.64M+30.7%2017-$11.01M-21.6%2016-$9.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share